4/A

PRIMARY DOCUMENT

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: August 19, 2016
Period of Report: August 16, 2016
Accession Number: 0001250853-16-000170

View Document ↗ View on SEC.gov ↗